Donath M Y, Zierhut W, Gosteli-Peter M A, Hauri C, Froesch E R, Zapf J
Department of Medicine, University Hospital, Zürich, Switzerland.
Eur J Endocrinol. 1998 Jul;139(1):109-17. doi: 10.1530/eje.0.1390109.
Adult rat cardiomyocytes in long-term culture reexpress several fetal cardiac proteins which also reappear during overload heart hypertrophy in vivo. IGF-I decreases reexpression of some of these proteins and stimulates myofibrillogenesis. IGF-I might therefore contribute to enhancing readaptation of the heart to overload. In order to test this hypothesis, hypertension was induced in male Wistar Kyoto rats by constriction of the left renal artery, and an infusion of 500 microg/day of recombinant human IGF-I (rhIGF-I) or vehicle was started after the operation via intraabdominally implanted osmotic minipumps. In the vehicle-treated hypertensive animals body weight gain was reduced after 3, 7 and 14 days, whereas rhIGF-I-treated hypertensive animals continued to gain weight like sham-operated animals. Left ventricular weight and the left, but not the right ventricle/body weight ratio increased more in rhIGF-I- than in vehicle-infused rats. Left ventricular IGF-I mRNA levels remained unchanged after renal clipping in both vehicle- and rhIGF-I-treated rats. However, beta-myosin heavy chain (MHC) mRNA in the left ventricle was 6- to 10-fold increased in clipped controls during the whole postoperative period, and rhIGF-I reduced this increase by more than 50% on days 7 and 14. On the first postoperative day, rhIGF-I prevented the decrease (50%) of alpha-MHC mRNA and the increase (2.5-fold of atrial natriuretic factor mRNA in the left ventricle. Renal clipping did not alter cardiac alpha-actin, but enhanced skeletal alpha-actin mRNA expression in the left ventricle up to 2.5-fold. However, both mRNAs were unaffected by rhIGF-I treatment. Restoration of body weight gain and stimulation of left ventricular cardiac weight by rhIGF-I as well as partial reversion of hypertension-induced changes in cardiac protein expression may reflect beneficial effects contributing to enhance readaptation of the heart to overload.
长期培养的成年大鼠心肌细胞会重新表达几种胎儿心脏蛋白,这些蛋白在体内心脏负荷过重肥大时也会再次出现。胰岛素样生长因子-I(IGF-I)可减少其中一些蛋白的重新表达,并刺激肌原纤维生成。因此,IGF-I可能有助于增强心脏对负荷过重的重新适应。为了验证这一假设,通过结扎左肾动脉在雄性Wistar Kyoto大鼠中诱导高血压,并在手术后通过腹腔内植入的渗透微型泵开始输注500微克/天的重组人IGF-I(rhIGF-I)或赋形剂。在接受赋形剂治疗的高血压动物中,术后3天、7天和14天体重增加减少,而接受rhIGF-I治疗的高血压动物继续像假手术动物一样体重增加。与输注赋形剂的大鼠相比,接受rhIGF-I治疗的大鼠左心室重量以及左心室/体重比(而非右心室/体重比)增加得更多。在接受赋形剂和rhIGF-I治疗的大鼠中,肾动脉夹闭后左心室IGF-I mRNA水平均保持不变。然而,在整个术后期间,夹闭对照组左心室中的β-肌球蛋白重链(MHC)mRNA增加了6至10倍,而rhIGF-I在第7天和第14天将这种增加降低了50%以上。在术后第一天,rhIGF-I可防止左心室中α-MHC mRNA减少(50%)以及心房利钠因子mRNA增加(2.5倍)。肾动脉夹闭并未改变心脏α-肌动蛋白,但可使左心室中骨骼肌α-肌动蛋白mRNA表达增加至2.5倍。然而,这两种mRNA均不受rhIGF-I治疗的影响。rhIGF-I恢复体重增加并刺激左心室重量,以及部分逆转高血压引起的心脏蛋白表达变化,可能反映了有助于增强心脏对负荷过重重新适应的有益作用。